Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Filings indexed 1,223 across all filing types
Latest filing 2013-11-04 Regulatory Filings
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings
2013-11-04 English
FORM 6-K
Regulatory Filings
2013-11-01 English
FORM 6-K
Regulatory Filings
2013-10-24 English
FORM 6-K
Regulatory Filings
2013-10-23 English
FORM 6-K
Regulatory Filings
2013-10-21 English
FORM 6-K
Regulatory Filings
2013-10-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.